These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 26278659)

  • 1. Intranasal immunization with protective antigen of Bacillus anthracis induces a long-term immunological memory response.
    Woo SJ; Kang SS; Park SM; Yang JS; Song MK; Yun CH; Han SH
    Mol Immunol; 2015 Oct; 67(2 Pt B):492-500. PubMed ID: 26278659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen.
    Boyaka PN; Tafaro A; Fischer R; Leppla SH; Fujihashi K; McGhee JR
    J Immunol; 2003 Jun; 170(11):5636-43. PubMed ID: 12759444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasal immunization with a dual antigen anthrax vaccine induced strong mucosal and systemic immune responses against toxins and bacilli.
    Sloat BR; Cui Z
    Vaccine; 2006 Sep; 24(40-41):6405-13. PubMed ID: 16828937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased long-term immunity to Bacillus anthracis protective antigen in mice immunized with a CIA06B-adjuvanted anthrax vaccine.
    Wui SR; Han JE; Kim YH; Rhie GE; Lee NG
    Arch Pharm Res; 2013 Apr; 36(4):464-71. PubMed ID: 23440578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The adjuvant effect of CpG oligodeoxynucleotide linked to the non-toxic B subunit of cholera toxin for induction of immunity against H. pylori in mice.
    Nyström-Asklin J; Adamsson J; Harandi AM
    Scand J Immunol; 2008 May; 67(5):431-40. PubMed ID: 18298617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits.
    Wimer-Mackin S; Hinchcliffe M; Petrie CR; Warwood SJ; Tino WT; Williams MS; Stenz JP; Cheff A; Richardson C
    Vaccine; 2006 May; 24(18):3953-63. PubMed ID: 16530302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contributions of edema factor and protective antigen to the induction of protective immunity by Bacillus anthracis edema toxin as an intranasal adjuvant.
    Duverger A; Carré JM; Jee J; Leppla SH; Cormet-Boyaka E; Tang WJ; Tomé D; Boyaka PN
    J Immunol; 2010 Nov; 185(10):5943-52. PubMed ID: 20952678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal immunization with Mycobacterium tuberculosis Rv3615c induces sustained adaptive CD4
    Li J; Zhao J; Shen J; Wu C; Liu J
    J Cell Mol Med; 2019 Jan; 23(1):596-609. PubMed ID: 30353641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ovine nasal mucosa: an alternative tissue site for mucosal immunization.
    Sedgmen BJ; Lofthouse SA; Meeusen EN
    Methods; 2006 Feb; 38(2):112-6. PubMed ID: 16427306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A plant based protective antigen [PA(dIV)] vaccine expressed in chloroplasts demonstrates protective immunity in mice against anthrax.
    Gorantala J; Grover S; Goel D; Rahi A; Jayadev Magani SK; Chandra S; Bhatnagar R
    Vaccine; 2011 Jun; 29(27):4521-33. PubMed ID: 21504775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal immunity to HIV-1: systemic and vaginal antibody responses after intranasal immunization with the HIV-1 C4/V3 peptide T1SP10 MN(A).
    Staats HF; Nichols WG; Palker TJ
    J Immunol; 1996 Jul; 157(1):462-72. PubMed ID: 8683152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal memory B cells retain the ability to produce IgM antibodies 2 years after oral immunization.
    Vajdy M; Lycke N
    Immunology; 1995 Nov; 86(3):336-42. PubMed ID: 8550068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of antibody-secreting cells and antigen-specific T cells in cervical lymph nodes after intranasal immunization.
    Wu HY; Nikolova EB; Beagley KW; Eldridge JH; Russell MW
    Infect Immun; 1997 Jan; 65(1):227-35. PubMed ID: 8975916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in infected mice.
    Kohama H; Umemura M; Okamoto Y; Yahagi A; Goga H; Harakuni T; Matsuzaki G; Arakawa T
    Vaccine; 2008 Feb; 26(7):924-32. PubMed ID: 18192091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal coadministration of Cholera toxin with amoeba lysates modulates the secretion of IgA and IgG antibodies, production of cytokines and expression of pIgR in the nasal cavity of mice in the model of Naegleria fowleri meningoencephalitis.
    Carrasco-Yepez M; Campos-Rodriguez R; Lopez-Reyes I; Bonilla-Lemus P; Rodriguez-Cortes AY; Contis-Montes de Oca A; Jarillo-Luna A; Miliar-Garcia A; Rojas-Hernandez S
    Exp Parasitol; 2014 Nov; 145 Suppl():S84-92. PubMed ID: 24731967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nasal immunization with major epitope-containing ApxIIA toxin fragment induces protective immunity against challenge infection with Actinobacillus pleuropneumoniae in a murine model.
    Seo KW; Kim SH; Park J; Son Y; Yoo HS; Lee KY; Jang YS
    Vet Immunol Immunopathol; 2013 Jan; 151(1-2):102-12. PubMed ID: 23200821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of antigen-specific T- and B-cell memory in local as well as systemic lymphoid tissues following oral immunization with cholera toxin adjuvant.
    Vajdy M; Lycke N
    Immunology; 1993 Oct; 80(2):197-203. PubMed ID: 7505255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of Bacillus anthracis surface protein EA1 against anthrax in mice.
    Uchida M; Harada T; Enkhtuya J; Kusumoto A; Kobayashi Y; Chiba S; Shyaka A; Kawamoto K
    Biochem Biophys Res Commun; 2012 May; 421(2):323-8. PubMed ID: 22507985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen-specific CD4+ T cells recognize epitopes of protective antigen following vaccination with an anthrax vaccine.
    Laughlin EM; Miller JD; James E; Fillos D; Ibegbu CC; Mittler RS; Akondy R; Kwok W; Ahmed R; Nepom G
    Infect Immun; 2007 Apr; 75(4):1852-60. PubMed ID: 17283103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nasal immunization with the mixture of PA63, LF, and a PGA conjugate induced strong antibody responses against all three antigens.
    Sloat BR; Shaker DS; Le UM; Cui Z
    FEMS Immunol Med Microbiol; 2008 Mar; 52(2):169-79. PubMed ID: 18194342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.